Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “LTD.”

1,301 pharma patents match "LTD." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,301
Index total 30,257
Page 7 / 55

Quick answer

This filtered view shows 1,301 pharmaceutical patents matching "LTD." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,301 results for “LTD.” · 30,257 patents in full index Clear search

  1. US 11633385

    Combination compositions for treatment of cancer

    RedHill Biopharma Ltd. · Granted Apr 25, 2023 · Expires Apr 20, 2043

    granted
  2. US 11623010

    Pharmaceutical carrier in the preparation of an anti-diabetic pharmaceutical composition and methods for treatment

    BEIJING RONGXIANG INSTITUTE OF REGENERATIVE MEDICINE CO., LTD. · Granted Apr 11, 2023 · Expires Apr 6, 2043

    granted
  3. US 11617796

    Conjugate of minoxidil and peptide

    CAREGEN CO., LTD. · Granted Apr 4, 2023 · Expires Mar 30, 2043

    granted
  4. US 11617769

    Methods of transdifferentiation and methods of use thereof

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Apr 4, 2023 · Expires Mar 30, 2043

    granted
  5. US 11613551

    Aminoglycoside derivatives and uses thereof in treating genetic disorders

    ELOXX PHARMACEUTICALS LTD. · Granted Mar 28, 2023 · Expires Mar 23, 2043

    granted
  6. US 11607435

    Probiotics Bifidobacteria strains

    PERFECT (CHINA) CO., LTD. · Granted Mar 21, 2023 · Expires Mar 16, 2043

    granted
  7. US 11597748

    Peptide having cytoprotective effect against environmental pollutant and use thereof

    CAREGEN CO., LTD. · Granted Mar 7, 2023 · Expires Mar 2, 2043

    granted
  8. US 11590154

    Triple antibiotic fixed-dose combination products, dosing regimen, methods, and kits for treating pulmonary non-tuberculosis mycobacterial infections

    RedHill Biopharma Ltd. · Granted Feb 28, 2023 · Expires Feb 23, 2043

    granted
  9. US 11564891

    Chloroquine gel and preparation method and application thereof

    GUANGZHOU HYBRIBIO BIOTECH LTD. · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted
  10. US 11560354

    Compositions comprising (R)-2-amino-3-phenylpropyl carbamate and uses thereof

    AXSOME MALTA LTD. · Granted Jan 24, 2023 · Expires Jan 19, 2043

    granted
  11. US 11517569

    Vilazodone inclusion complexes, compositions and preparation thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Dec 6, 2022 · Expires Dec 1, 2042

    granted
  12. US 11518785

    Peptide showing melanogenesis promoting activity and use thereof

    CAREGEN CO., LTD. · Granted Dec 6, 2022 · Expires Dec 1, 2042

    granted
  13. US 11517606

    Composition having anti-glycation effect and application thereof

    INFINITUS (CHINA) COMPANY LTD. · Granted Dec 6, 2022 · Expires Dec 1, 2042

    granted
  14. US 11512112

    Peptide for suppressing osteoclast differentiation and use thereof

    CAREGEN CO., LTD. · Granted Nov 29, 2022 · Expires Nov 24, 2042

    granted
  15. US 11505525

    Branched discrete PEG constructs

    Quanta BioDesign, Ltd. · Granted Nov 22, 2022 · Expires Nov 17, 2042

    granted
  16. US 11497725

    Treatment for obesity

    AXSOME MALTA LTD. · Granted Nov 15, 2022 · Expires Nov 10, 2042

    granted
  17. US 11497793

    Compositions and methods for treating glioblastoma

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Nov 15, 2022 · Expires Nov 10, 2042

    granted
  18. US 11472772

    S1P3 antagonists

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Oct 18, 2022 · Expires Oct 13, 2042

    granted
  19. US 11471448

    Sphingosine kinase 2 inhibitor for treating coronavirus infection in moderately severe patients with pneumonia

    RedHill Biopharma Ltd. · Granted Oct 18, 2022 · Expires Oct 13, 2042

    granted
  20. US 11471534

    Chitosan-pluronic complex and nano-carrier comprising same

    SKINMED CO., LTD. · Granted Oct 18, 2022 · Expires Oct 13, 2042

    granted
  21. US 11472840

    Acetylcholine receptor-binding peptide

    SKINMED CO., LTD. · Granted Oct 18, 2022 · Expires Oct 13, 2042

    granted
  22. US 11453700

    Peptide having activities of skin whitening and uses thereof

    CAREGEN CO., LTD. · Granted Sep 27, 2022 · Expires Sep 22, 2042

    granted
  23. US 11453870

    Ligase fusion proteins and application thereof

    GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD. · Granted Sep 27, 2022 · Expires Sep 22, 2042

    granted
  24. US 11446323

    Compositions and methods for the treatment of fibrotic diseases

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted